Cargando…

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea

The prevalence of diabetes in Korea has increased six- to sevenfold over the past 40 years with its complications becoming major causes of morbidity and mortality. The rate of death among patients with diabetes is about twice as high as that among persons without diabetes and the most common cause o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Hee, Kim, Dae Jung, Jang, Hak Chul, Choi, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253966/
https://www.ncbi.nlm.nih.gov/pubmed/22247898
http://dx.doi.org/10.4093/dmj.2011.35.6.571
_version_ 1782220785412210688
author Kim, Jung Hee
Kim, Dae Jung
Jang, Hak Chul
Choi, Sung Hee
author_facet Kim, Jung Hee
Kim, Dae Jung
Jang, Hak Chul
Choi, Sung Hee
author_sort Kim, Jung Hee
collection PubMed
description The prevalence of diabetes in Korea has increased six- to sevenfold over the past 40 years with its complications becoming major causes of morbidity and mortality. The rate of death among patients with diabetes is about twice as high as that among persons without diabetes and the most common cause of death is cardiovascular disease (30.6%). Despite the seriousness of diabetic complications, 30 to 70% of patients receive inadequate care, and only 40% of treated diabetic patients achieve the optimal control with HbA1c level <7% in Korea. In 2006, over 30 to 40% of patients with diabetes have microvascular complications and around 10% of them have macrovascular complications from our national data. Despite there are some debates about intensive glycemic control resulting in the deterioration of macrovascular complication, multifactorial treatment approaches including proper glycemic control are important to prevent diabetic complications. There have been needs for finding proper biomarkers for predicting diabetic complications properly but we still need more longitudinal studies to find this correlation with causal relationship. In this article, we wanted to review the recent status of micro- and macrovascular complications of type 2 diabetes in Korea from integration of many epidemiologic studies.
format Online
Article
Text
id pubmed-3253966
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-32539662012-01-13 Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea Kim, Jung Hee Kim, Dae Jung Jang, Hak Chul Choi, Sung Hee Diabetes Metab J Review The prevalence of diabetes in Korea has increased six- to sevenfold over the past 40 years with its complications becoming major causes of morbidity and mortality. The rate of death among patients with diabetes is about twice as high as that among persons without diabetes and the most common cause of death is cardiovascular disease (30.6%). Despite the seriousness of diabetic complications, 30 to 70% of patients receive inadequate care, and only 40% of treated diabetic patients achieve the optimal control with HbA1c level <7% in Korea. In 2006, over 30 to 40% of patients with diabetes have microvascular complications and around 10% of them have macrovascular complications from our national data. Despite there are some debates about intensive glycemic control resulting in the deterioration of macrovascular complication, multifactorial treatment approaches including proper glycemic control are important to prevent diabetic complications. There have been needs for finding proper biomarkers for predicting diabetic complications properly but we still need more longitudinal studies to find this correlation with causal relationship. In this article, we wanted to review the recent status of micro- and macrovascular complications of type 2 diabetes in Korea from integration of many epidemiologic studies. Korean Diabetes Association 2011-12 2011-12-26 /pmc/articles/PMC3253966/ /pubmed/22247898 http://dx.doi.org/10.4093/dmj.2011.35.6.571 Text en Copyright © 2011 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kim, Jung Hee
Kim, Dae Jung
Jang, Hak Chul
Choi, Sung Hee
Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
title Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
title_full Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
title_fullStr Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
title_full_unstemmed Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
title_short Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
title_sort epidemiology of micro- and macrovascular complications of type 2 diabetes in korea
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253966/
https://www.ncbi.nlm.nih.gov/pubmed/22247898
http://dx.doi.org/10.4093/dmj.2011.35.6.571
work_keys_str_mv AT kimjunghee epidemiologyofmicroandmacrovascularcomplicationsoftype2diabetesinkorea
AT kimdaejung epidemiologyofmicroandmacrovascularcomplicationsoftype2diabetesinkorea
AT janghakchul epidemiologyofmicroandmacrovascularcomplicationsoftype2diabetesinkorea
AT choisunghee epidemiologyofmicroandmacrovascularcomplicationsoftype2diabetesinkorea